8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)

2026-10-01 15:17:15.329498+02

Economic importance 82/100 Credibility 81/100

Event subtypematerial_event

Filing form8-K

IssuerApimeds Pharmaceuticals US, Inc. (Filer)

Visibilityprimary

What happened

Filed: 2026-09-11 AccNo: 0001213900-26-099002 Size: 239 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Affected entities

Andorra Uncertain Impact 72/100 · Confidence 71% Venezuela Uncertain Impact 72/100 · Confidence 71% Türkiye Uncertain Impact 72/100 · Confidence 71%

Sources used

SEC EDGAR — Latest filings 2026-10-01 15:15:15+02 · 96/100

Open original source

SEC EDGAR — Latest filings 2026-09-29 22:15:29+02 · 96/100

Open original source

SEC EDGAR — Latest filings 2026-09-11 15:10:36+02 · 96/100

Open original source